Clinical Trials Directory

Trials / Unknown

UnknownNCT01232023

Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
Male
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate the pharmacokinetic and pharmacodynamic characteristics of indobufen in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGIndobufenSingle Oral Dose of

Timeline

Start date
2010-01-01
Primary completion
2010-12-01
First posted
2010-11-02
Last updated
2010-11-10

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01232023. Inclusion in this directory is not an endorsement.